middle.news
LTR Pharma Secures US ROXUS Deals and Advances SPONTAN FDA Pathway
7:48am on Friday 28th of August, 2026 AEST
•
Healthcare
Read Story
LTR Pharma Secures US ROXUS Deals and Advances SPONTAN FDA Pathway
7:48am on Friday 28th of August, 2026 AEST
Key Points
Over 1,000 SPONTAN prescriptions in Australia
Binding US agreements for ROXUS telehealth and pharmacy
SPONTAN Phase II interim data shows 10-minute onset
OROFLOW intranasal study approved for oesophageal disorders
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Ltr Pharma (ASX:LTP)
OPEN ARTICLE